(Total Views: 191)
Posted On: 03/02/2017 3:38:34 PM
Post# of 102371
$RGBP Regen BioPharma, Inc. Licenses NR2F6 Technology for Cancer Treatment and Autoimmune Disorders to CheckPoint Immunology Inc.
http://finance.yahoo.com/news/regen-biopharma...00603.html
http://finance.yahoo.com/news/regen-biopharma...00603.html
(0)
(0)
Scroll down for more posts ▼